The current market environment remains choppy, so we want to revisit a sector that’s showing relative strength, Pharma.
In November we pointed to the improving prospects of the Nifty Pharma Index and its components, following up with additional trades in January.
Today, we want to revisit the sector to see what’s changed and what stocks we want to be buying and selling.